BioSpace News Archive

Alexion Pharmaceuticals, Inc. announced financial results for the first quarter of 2020.

Applied Genetic Technologies Corporation, a biotechnology company conducting human clinical trials of adeno-associated virus -based gene therapies for the treatment of rare diseases, announced that it will report financial results for the fiscal quarter ended March 31, 2020 before the market opens on Wednesday, May 13, 2020.

Study was rated in the top 10% of all abstracts in this category and was selected as Poster of Distinction

Constellation Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company using its expertise in epigenetics to discover and develop novel therapeutics, announced its first-quarter 2020 financial results.

Viela Bio announced it will host a webcast and conference call on Wednesday, May 13, 2020 at 5:00 p.m. ET to discuss its first quarter 2020 financial results and program highlights.

Announced 14 presentations at upcoming American Society of Gene and Cell Therapy (ASGCT) Virtual Annual Meeting highlighting Huntington’s disease, ALS SOD1, vectorized antibodies, novel capsids, and manufacturing

Microbix Biosystems Inc., an award-winning life sciences innovator and exporter, announces that it has begun providing its REDx™FLOQ® SARS-CoV-2 swab-format and REDx™ SARS-CoV-2 vial format quality assessment products as controls to clinical laboratories in Canada.

BioCryst Pharmaceuticals, Inc. announced financial results for the first quarter ended March 31, 2020, and provided a corporate update.

New Ion AmpliSeq SARS-CoV-2 Research Panel, now optimized for the Ion Torrent Genexus System*, assists with contact tracing to identify coronavirus hot spots

Blueprint Medicines Corporation, a precision therapy company focused on genomically defined cancers, rare diseases and cancer immunotherapy, reported financial results and provided a business update for the first quarter ended March 31, 2020.